18F-fluorodeoxyglucose positron emission tomography in evaluation of germ cell tumor after chemotherapy

Urology

Volumn 64, Issue 6, 2004, Pages 1202-1207

  Putra, L Johns ^a,b   Lawrentschuk, N ^a,c   Ballok, Z ^b   Hannah, A ^b,c   Poon, A ^b,c   Tauro, A ^b   Davis, I D ^c,d   Hicks, R J ^e   Bolton, D M ^a   Scott, A M ^b,c,d  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b Centre for PET   (Australia)

^c LUDWIG INSTITUTE FOR CANCER RESEARCH   (Australia)

^d AUSTIN HOSPITAL   (Australia)

^e PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GERM CELL TUMOR; HISTOLOGY; HUMAN; IMAGING; MALE; NON SEMINOMATOUS GERMINOMA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SEMINOMA; TESTIS TERATOMA; THYROID ADENOMA; TREATMENT OUTCOME; ARTICLE; MIDDLE AGED; MINIMAL RESIDUAL DISEASE; PATHOLOGY; SALVAGE THERAPY; SCINTISCANNING;

ADULT; ANTINEOPLASTIC AGENTS; FEMALE; FLUORODEOXYGLUCOSE F18; GERMINOMA; HUMANS; MALE; MIDDLE AGED; NEOPLASM, RESIDUAL; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; SALVAGE THERAPY; SEMINOMA;

EID: 10644282063     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urology.2004.07.024     Document Type: Article

References (21)

1. K. Ganjoo, R. Chan, M. Sharma Positron emission tomography scans in the evaluation of postchemotherapy residual masses in patients with seminoma J Clin Oncol 17 1999 3457 3460
2. C. Bokemeyer, C. Nichols, J.-P. Droz Extragonadal germ cell tumors of the mediastinum and retroperitoneum results from an international analysis J Clin Oncol 20 2002 1864 1873
3. L. Einhorn, A.W. Stephens, R. Gonin, G.D. Hutchins Treatment of testicular cancer a new and improved model J Clin Oncol 8 1990 1777 1781
4. R. Thomas, D. Dearnaley, J. Nicholls An analysis of surveillance for stage I combined teratoma-seminoma of the testis Br J Cancer 74 1996 59 62
5. E. Steyerberg, H. Keizer, S. Fossa Prediction of residual retroperitoneal mass histology after chemotherapy for metastatic nonseminomatous germ cell tumor multivariate analysis of individual patient data from six study groups J Clin Oncol 13 1995 1177 1187
6. S. Stenning, M. Parkinson, C. Fisher Postchemotherapy residual masses in germ cell tumor patients Cancer 83 1998 1409 1419
7. S.D. Beck, R.S. Foster, R. Bihrle Teratoma in the orchiectomy specimen and volume of metastasis are predictors of retroperitoneal teratoma in post-chemotherapy nonseminomatous testis cancer J Urol 168 2002 1402 1404
8. J. Hartmann, H.-J. Schmol, M. Kuczyk Postchemotherapy resection of residual masses from metastatic nonseminomatous testicular germ cell tumors Ann Oncol 8 1997 531 538
9. 18Fluoro-deoxy-d- glucose positron emission tomography is a reliable predictor for viable tumor in postchemotherapy seminoma an update of the prospective multicentric SEMPET trial J Clin Oncol 22 2004 1034 1039
10. 18F]FDG PET Br J Cancer 86 2002 506 511
11. A. Scott Current status of positron emission tomography in oncology Australas Radiol 46 2002 154 162
12. 18fluoro-2-deoxy-d-glucose positron emission tomography for residual postchemotherapy masses in patients with bulky seminoma J Clin Oncol 19 2001 3740 3744
13. 18F]fluorodeoxyglucose positron emission tomography with conventional assessment by computed tomography scans and serum tumor markers for the evaluation of residual masses in patients with nonseminomatous germ cell carcinoma Cancer 94 2002 2353 2362
14. J. Bomanji, D. Costa, P. Ell Clinical role of positron emission tomography in oncology Lancet Oncol 2 2001 157 164
15. S. Ramdave, G.W. Thomas, S.U. Berlangieri Clinical role of F-18 fluorodeoxyglucose positron emission tomography for detection and management of renal cell carcinoma J Urol 166 2001 825 830
16. C. Wilson, H. Young, R. Ott Imaging metastatic testicular germ cell tumours with F18-FDG positron emission tomography prospects for detection and management Eur Nuclear Med 22 1995 508 513
17. A. Stephens, R. Gonin, H. GD Positron emission tomography evaluation of residual radiographic abnormalities in postchemotherapy germ cell tumor patients J Clin Oncol 14 1996 1637 1641
18. E. Steyerberg, H. Keizer, D. Sleijfer Retroperitoneal metastases in testicular cancer role of CT measurements in decision making for resection after chemotherapy Radiology 215 2000 437 444
19. C.L. Coogan, M.J. Hejase, G.R. Wahle Nerve sparing post-chemotherapy retroperitoneal lymph node dissection for advanced testicular cancer J Urol 156 1996 1656 1658
20. S. Hain, M. O'Doherty, A. Timothy Fluorodeoxyglucose PET in the initial staging of germ cell tumours Eur J Nuclear Med 27 2000 590 594
21. C. Wilson PET scanning in oncology Eur J Cancer 28 1992 508 510